Evidence map›Paper›PMID 32533615›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2020

Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.

Oscar K Serrano, Heather L Kutzler, Caroline Rochon, Joseph A Radojevic, Michael T Lawlor, Jonathan A Hammond, Jason Gluck, Andrew D Feingold, Abhishek Jaiswal

Open access · greenAbstract readCase Reports
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Oscar K SerranoHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.ORCID https://orcid.org/0000-0001-5076-0938
Heather L KutzlerHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.ORCID https://orcid.org/0000-0002-0106-9822
Caroline RochonHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Joseph A RadojevicHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Michael T LawlorHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Jonathan A HammondHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Jason GluckHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Andrew D FeingoldHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Abhishek JaiswalHartford Hospital Transplant & Comprehensive Liver Center, Hartford, Connecticut, USA.
Hartford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical course and outcomes of immunocompromised patients, such as transplant recipients, with COVID-19 remain unclear. It has been postulated that a substantial portion of the disease burden seems to be mediated by the host immune activation to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present a simultaneous heart-kidney transplant (SHKT) recipient who was hospitalized for the management of respiratory failure from volume overload complicated by failure to thrive, multiple opportunistic infections, and open non-healing wounds in the setting of worsening renal dysfunction weeks prior to the first case of SARS-CoV-2 being detected in the state of Connecticut. After his third endotracheal intubation, routine nucleic acid testing (NAT) for SARS-CoV-2, in anticipation of a planned tracheostomy, was positive. His hemodynamics, respiratory status, and ventilator requirements remained stable without any worsening for 4 weeks until he had a negative NAT test. It is possible that the immunocompromised status of our patient may have prevented significant immune activation leading up to clinically significant cytokine storm that could have resulted in acute respiratory distress syndrome and multisystem organ failure.

Indexed as

Heart TransplantationKidney TransplantationAntibiotics, AntineoplasticBacteremiaBK VirusCardiomyopathy, DilatedCardiotoxicityCOVID-19COVID-19 Nucleic Acid TestingDoxorubicinGraft RejectionGram-Positive Bacterial InfectionsHumansImmunocompromised HostImmunosuppressive AgentsIncidental FindingsAntibiotics, AntineoplasticDoxorubicinImmunosuppressive AgentsMycophenolic AcidPrednisoneTacrolimusCOVID-19immunosuppressionSARS-CoV-2simultaneous heart-kidney transplant

Identifiers

PMID32533615
PMCPMC7323106
OpenAlexW3035272767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.